Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001085146-15-000613
Filing Date
2015-02-17
Accepted
2015-02-17 08:23:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 CONSONANCE CAPITAL MANAGEMENT LP plx_21315.htm SC 13G 48242
  Complete submission text file 0001085146-15-000613.txt   50008
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 15618046
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019
Business Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019 212.660-8062
Consonance Capital Management LP (Filed by) CIK: 0001544773 (see all company filings)

EIN.: 260294313 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G